ess invasive surfactantadministration (LISA) versusINtubation SURfactant Extubation(INSURE) in preterm infants withrespiratory distress syndrome: arandomised controlled trial

Prince pareek0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Spontaneously breathing preterm infants with RDS diagnosed within 24 hours of life from >=28 weeks 0 days to 36 weeks 6 daysâ?? gestational age with respiratory distress syndrome who will meet two or more criteria for surfactant therapy
•Those willing to participate in the study as consented by parents or relatives

•Infants with anatomical abnormalities of upper airway or major congenital anomalies
•Infants with conditions where nasal non-invasive ventilation is contraindicated such as â?? congenital diaphragmatic hernia, trachea-oesophageal fistula, choanal atresia, cleft palate and poor respiratory efforts
•Infants whose FiO2 requirement is >=60% or hemodynamically unstable infants who require intubation and invasive ventilation for stabilization and therefore cannot be given non-invasive ventilation.

发起方

Prince pareek